Table 1 Baseline characteristics of the study population
Characteristic | Total (n = 135) | DM (n = 55) | NDM (n = 80) | p value |
|---|---|---|---|---|
Age in years | 66.4 ± 10.9 | 67.6 ± 10.6 | 65.5 ± 11.1 | 0.279 |
Gender no. (%) | Â | 0.711 | ||
 Female | 45 (33.3 %) | 17 (30.9 %) | 28 (35 %) |  |
 Male | 90 (66.7 %) | 38 (69.1 %) | 52 (65 %) |  |
Cardiovascular risk factors no. (%) | ||||
 Arterial hypertension | 110 (81.5 %) | 50 (90.9 %) | 60 (75 %) | 0.024 |
 Hyperlipoproteinemia | 71 (52.6 %) | 29 (52.7 %) | 42 (52.5 %) | 0.979 |
 Family history of CAD | 40 (29.6 %) | 14 (25.5 %) | 16 (20 %) | 0.529 |
 Smoking | 29 (21.5 %) | 10 (18.2 %) | 19 (23.8 %) | 0.525 |
 Body mass index kg/m2 | 28.4 ± 5.2 | 30.5 ± 5.4 | 26.9 ± 4.5 | 0.001 |
Medical history no. (%) | ||||
 Previous MI (6 months) | 40 (29.6 %) | 16 (29.1 %) | 24 (30 %) | 0.910 |
 Previous bypass | 15 (11.1 %) | 8 (14.5 %) | 7 (8.8 %) | 0.404 |
 Previous stroke | 7 (5.2 %) | 3 (5.5 %) | 4 (5 %) | 0.907 |
 Chronic kidney disease | 4 (3.0 %) | 2 (3.6 %) | 2 (2.5 %) | 0.702 |
Coronary artery disease no. (%) | Â | 0.009 | ||
 3 vessels | 49 (36.3 %) | 24 (44.4 %) | 25 (31.7 %) |  |
 2 vessels | 37 (27.4 %) | 20 (37.0 %) | 17 (21.5 %) |  |
 1 vessel | 15 (11.1 %) | 3 (5.6 %) | 12 (15.2 %) |  |
 Left ventricular ejection fraction  (%) | 57.2 ± 12.2 | 60.0 ± 12.8 | 57.4 ± 11.8 | 0.831 |
Medication on admission no. (%) | ||||
 ACE inhibitors | 85 (63.0 %) | 35 (63.6 %) | 50 (62.5 %) | 0.893 |
 Angiotensin receptor blockers | 29 (21.5 %) | 13 (23.6 %) | 16 (20 %) | 0.672 |
 Beta blockers | 115 (85.2 %) | 45 (81.8 %) | 70 (87.5 %) | 0.461 |
 Calcium channel blockers | 28 (20.7 %) | 17 (30.9 %) | 11 (13.8 %) | 0.019 |
 Diuretics | 62 (45.9 %) | 27 (49.1 %) | 35 (43.8 %) | 0.600 |
 Statins | 109 (80.7 %) | 45 (81.8 %) | 64 (80 %) | 0.828 |
 Nitrates | 5 (3.7 %) | 1 (1.8 %) | 4 (5 %) | 0.648 |
 Aspirin | 115 (85.2 %) | 47 (85.5 %) | 58 (72.5 %) | 0.093 |
Laboratory parameters | ||||
 Glucose mg/dL | 126.4 ± 58.6 | 167.1 ± 72.3 | 99.0 ± 19.2 | 0.0001 |
 HbA1c (%) | 6.4 ± 1.0 | 7.2 ± 1.2 | 5.9 ± 0.4 | 0.0001 |
 Serum creatinine mg/dL | 0.98 ± 0.33 | 1.01 ± 0.33 | 0.97 ± 0.32 | 0.645 |
 Glomerular filtration rate mL/min | 65.1 ± 11.0 | 64.3 ± 12.4 | 65.7 ± 9.9 | 0.463 |
 Triglycerides mg/dL | 166.2 ± 204.5 | 199.4 ± 302.8 | 144.4 ± 84.2 | 0.137 |
 Cholesterol mg/dL | 184.645 ± 48.8 | 173.2 ± 44.6 | 192.5 ± 50.2 | 0.023 |
 HDL cholesterol mg/dL | 49.9 ± 17.7 | 45.2 ± 16.6 | 53.2 ± 17.8 | 0.009 |
 LDL cholesterol mg/dL | 110.3 ± 37.3 | 102.0 ± 34.2 | 116.0 ± 38.4 | 0.030 |
 C-reactive protein mg/L | 4.4 ± 6.5 | 4.5 ± 5.8 | 4.3 ± 7.0 | 0.826 |
 Leucocytes 109/L | 7.3 ± 2.1 | 7.3 ± 1.7 | 7.2 ± 2.3 | 0.807 |
 Concentration of Annexin V + MP/µl | 778.72 ± 1439.4 | 1144.0 ± 1849.4 | 526.2 ± 1009.1 | 0.014 |